Sangamo Therapeutics, Inc.
SGMO
$0.44
$0.00-0.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.45% | 38.00% | -53.73% | -48.25% | -70.33% |
| Total Receivables | -51.17% | 756.45% | 567.00% | 13.06% | 499.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.13% | -43.86% | -38.09% | -44.11% | -38.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.18% | 24.50% | -45.22% | -45.20% | -60.61% |
|
|
|||||
| Total Current Assets | -24.18% | 24.50% | -45.22% | -45.20% | -60.61% |
| Net Property, Plant & Equipment | -20.83% | -21.63% | -23.54% | -34.26% | -33.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.39% | 23.62% | -9.47% | -16.21% | -1.54% |
| Total Assets | -20.33% | 4.89% | -33.18% | -38.52% | -49.36% |
|
|
|||||
| Total Accounts Payable | -21.40% | -38.94% | 17.69% | 1.48% | 28.04% |
| Total Accrued Expenses | 22.83% | 79.37% | 37.57% | 8.70% | -30.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -6.01% | -- |
| Total Finance Division Other Current Liabilities | 448.73% | 49.77% | 1.12% | -27.96% | -7.27% |
| Total Other Current Liabilities | 448.73% | 49.77% | 1.12% | -27.96% | -7.27% |
| Total Current Liabilities | 16.13% | 22.19% | 23.16% | -4.04% | -10.98% |
|
|
|||||
| Total Current Liabilities | 16.13% | 22.19% | 23.16% | -4.04% | -10.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.31% | -19.37% | -19.28% | -21.67% | -20.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 452.05% | 459.41% | 466.14% | 473.46% | -5.84% |
| Total Liabilities | 14.24% | 12.45% | 12.45% | -4.33% | -14.92% |
|
|
|||||
| Common Stock & APIC | 4.80% | 3.60% | 1.80% | 2.73% | 2.47% |
| Retained Earnings | -7.35% | -4.24% | -5.46% | -6.96% | -10.02% |
| Treasury Stock & Other | 65.78% | 75.20% | 4.72% | -63.87% | 35.83% |
| Total Common Equity | -84.05% | -17.26% | -91.35% | -72.53% | -71.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -84.05% | -17.26% | -91.35% | -72.53% | -71.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -84.05% | -17.26% | -91.35% | -72.53% | -71.00% |
|
|
|||||